We haven't yet started the trial with that vaccine here in Canada. We're hoping it will start in the very near future.
That vaccine has undergone phase one and phase two studies in China. The phase one studies were quite successful and were published in The Lancet Infectious Diseases. Phase two studies have now been completed. My understanding is that those should be published within the next week or two in the same journal, also showing safety and good immunogenicity. With regard to the effectiveness or the efficacy of those vaccines, we will need to await the phase three studies that will be taking place.